176 related articles for article (PubMed ID: 26782170)
21. Investigation of mutations and expression of the FHIT gene in Turkish patients with brain metastases derived from non-small cell lung cancer.
Bekar A; Ceçener G; Tunca B; Guler G; Egeli U; Tolunay S
Tumori; 2007; 93(6):604-7. PubMed ID: 18338497
[TBL] [Abstract][Full Text] [Related]
22. System analysis of
Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
[TBL] [Abstract][Full Text] [Related]
23. Fhit tumor suppressor: guardian of the preneoplastic genome.
Pichiorri F; Palumbo T; Suh SS; Okamura H; Trapasso F; Ishii H; Huebner K; Croce CM
Future Oncol; 2008 Dec; 4(6):815-24. PubMed ID: 19086848
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF
Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768
[TBL] [Abstract][Full Text] [Related]
25. Reduction in squamous cell carcinomas in mouse skin by dietary zinc supplementation.
Sun J; Shen R; Schrock MS; Liu J; Pan X; Quimby D; Zanesi N; Druck T; Fong LY; Huebner K
Cancer Med; 2016 Aug; 5(8):2032-42. PubMed ID: 27185213
[TBL] [Abstract][Full Text] [Related]
26. Restored expression of fragile histidine triad protein and tumorigenicity of cervical carcinoma cells.
Wu R; Connolly DC; Dunn RL; Cho KR
J Natl Cancer Inst; 2000 Feb; 92(4):338-44. PubMed ID: 10675384
[TBL] [Abstract][Full Text] [Related]
27. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer.
Iliopoulos D; Guler G; Han SY; Johnston D; Druck T; McCorkell KA; Palazzo J; McCue PA; Baffa R; Huebner K
Oncogene; 2005 Feb; 24(9):1625-33. PubMed ID: 15674328
[TBL] [Abstract][Full Text] [Related]
28. Fhit-deficient hematopoietic stem cells survive hydroquinone exposure carrying precancerous changes.
Ishii H; Mimori K; Ishikawa K; Okumura H; Pichiorri F; Druck T; Inoue H; Vecchione A; Saito T; Mori M; Huebner K
Cancer Res; 2008 May; 68(10):3662-70. PubMed ID: 18483248
[TBL] [Abstract][Full Text] [Related]
29. Cancer prevention and therapy in a preclinical mouse model: impact of FHIT viruses.
Ishii H; Vecchione A; Fong LY; Zanesi N; Trapasso F; Furukawa Y; Baffa R; Huebner K; Croce CM
Curr Gene Ther; 2004 Mar; 4(1):53-63. PubMed ID: 15032614
[TBL] [Abstract][Full Text] [Related]
30. Nit1 and Fhit tumor suppressor activities are additive.
Sun J; Okumura H; Yearsley M; Frankel W; Fong LY; Druck T; Huebner K
J Cell Biochem; 2009 Aug; 107(6):1097-106. PubMed ID: 19479888
[TBL] [Abstract][Full Text] [Related]
31. Identification of Fhit as a post-transcriptional effector of Thymidine Kinase 1 expression.
Kiss DL; Waters CE; Ouda IM; Saldivar JC; Karras JR; Amin ZA; Mahrous S; Druck T; Bundschuh RA; Schoenberg DR; Huebner K
Biochim Biophys Acta Gene Regul Mech; 2017 Mar; 1860(3):374-382. PubMed ID: 28093273
[TBL] [Abstract][Full Text] [Related]
32. Development of spontaneous tumours and intestinal lesions in Fhit gene knockout mice.
Fujishita T; Doi Y; Sonoshita M; Hiai H; Oshima M; Huebner K; Croce CM; Taketo MM
Br J Cancer; 2004 Oct; 91(8):1571-4. PubMed ID: 15467769
[TBL] [Abstract][Full Text] [Related]
33. FHIT gene therapy prevents tumor development in Fhit-deficient mice.
Dumon KR; Ishii H; Fong LY; Zanesi N; Fidanza V; Mancini R; Vecchione A; Baffa R; Trapasso F; During MJ; Huebner K; Croce CM
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3346-51. PubMed ID: 11248081
[TBL] [Abstract][Full Text] [Related]
34. Influence of FHIT on benzo[a]pyrene-induced tumors and alopecia in mice: chemoprevention by budesonide and N-acetylcysteine.
Balansky R; D'Agostini F; Ganchev G; Izzotti A; Di Marco B; Lubet RA; Zanesi N; Croce CM; De Flora S
Proc Natl Acad Sci U S A; 2006 May; 103(20):7823-8. PubMed ID: 16672365
[TBL] [Abstract][Full Text] [Related]
35. Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.
Pavelić K; Krizanac S; Cacev T; Hadzija MP; Radosević S; Crnić I; Levanat S; Kapitanović S
Mol Med; 2001 Jul; 7(7):442-53. PubMed ID: 11683369
[TBL] [Abstract][Full Text] [Related]
36. Regression of upper gastric cancer in mice by FHIT gene delivery.
Ishii H; Zanesi N; Vecchione A; Trapasso F; Yendamuri S; Sarti M; Baffa R; During MJ; Huebner K; Fong LY; Croce CM
FASEB J; 2003 Sep; 17(12):1768-70. PubMed ID: 12958204
[TBL] [Abstract][Full Text] [Related]
37. Influence of a nonfragile FHIT transgene on murine tumor susceptibility.
McCorkell KA; Mancini R; Siprashvili Z; Barnoski BL; Iliopoulos D; Siracusa LD; Zanesi N; Croce CM; Fong LY; Druck T; Huebner K
Cytogenet Genome Res; 2007; 118(2-4):196-203. PubMed ID: 18000371
[TBL] [Abstract][Full Text] [Related]
38. Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos.
Nelson HH; Wiencke JK; Gunn L; Wain JC; Christiani DC; Kelsey KT
Cancer Res; 1998 May; 58(9):1804-7. PubMed ID: 9581816
[TBL] [Abstract][Full Text] [Related]
39. Impact of FHIT loss on the translation of cancer-associated mRNAs.
Kiss DL; Baez W; Huebner K; Bundschuh R; Schoenberg DR
Mol Cancer; 2017 Dec; 16(1):179. PubMed ID: 29282095
[TBL] [Abstract][Full Text] [Related]
40. Inactivation of both FHIT and p53 cooperate in deregulating proliferation-related pathways in lung cancer.
Andriani F; Roz E; Caserini R; Conte D; Pastorino U; Sozzi G; Roz L
J Thorac Oncol; 2012 Apr; 7(4):631-42. PubMed ID: 22425911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
